Sharmin Nahar

Sharmin Nahar is an experienced professional in the biotechnology field, currently serving as an Upstream Process Development Scientist at Northway Biotech since October 2022. Prior to this role, Sharmin worked as a Research Associate in Upstream CMC at Entrada Therapeutics from March 2022 to October 2022 and as Associate 1 at Seres Therapeutics from December 2020 to March 2022. Academic qualifications include a Master of Science in Biotechnology with a concentration in Molecular Biotechnology from Northeastern University, obtained in May 2023, a Bachelor of Science in Biotechnology from Northeastern University in 2021, and an Associate's degree in Biotechnology from Quincy College in 2019.